molecular signatures that will differentiate among various clinical phenotypes of HELLP and provide an accurate differential diagnosis of this syndrome from HELLP imitators. STUDY DESIGN: We analyzed urine samples from 6 groups of patients classified phenotypically as: non-hypertensive healthy controls (CRL, n¼9, 30AE1 wks), women with idiopathic proteinuria (IP, n¼15, 28AE2 wks), PE mild features (mPE, n¼16, 33AE1 wks), superimposed PE (spPE, n¼16, 31AE1 wks), PE severe features (sPE, n¼16, 32AE1 wks) and HELLP (n¼16, 29AE1 wks). In the discovery phase, urine proteins were enriched by CR precipitation and subjected to UPLC-tandem mass spectrometry. The data were analyzed with Myrimatch and IDPicker. Theoretical masses were calculated from the human Uniprot sequence database. Protein IDs from all samples were dimensionally reduced using multi-dimensional scaling. HELLP samples were clustered (Euclidean distance, average linkage) using silhouette score to control clustering quality. Characteristic proteins for the clusters were determined by variance analysis. RESULTS: 1,747 IDs were identified in the CR precipitate and merged into 690 protein groups. The false discovery rate was 1.12%. These IDs generated good separation for 3 major clinical phenotypes (Figure) . Variance analysis yielded Immunoglobulin Kappa Locus protein and Immunoglobulin-like protein (role: immunoglobulin synthesis) for cluster 1, Keratin types I and II for cluster 2 (role: structural framework of epithelial cells), and three Alpha-1-Antitrypsin (A0A024R6I7, Q3I0J7, A7L8C5) variants (role: endogenous protease inhibitor) for cluster 3. CONCLUSION: We provide evidence that HELLP syndrome involves 3 subclinical phenotypes that can be differentiated through examination of the urinary misfoldome.
511 New-onset postpartum preeclampsia: Mechanisms and Prediction 
OBJECTIVE:
The development of new-onset postpartum preeclampsia (NOPP) long after placental delivery is neither understood nor can it be predicted. Epigenomics was used to interrogate the pathogeneses of and to predict NOPP. STUDY DESIGN: NOPP was defined as post-partum preeclampsia developing !48 hours after delivery with no prior hypertensionrelated disorders. Placental tissue was obtained from 12 NOPP cases and 12 normotensive controls. Genome-wide cytosine (CpG) methylation assay using the Infinium MethylationEPIC BeadChip array (Illumina) was performed. Significant differential methylation at the individual CpG locus was defined as False Discovery Rate (FDR) of p-value <0.05. The area under the receiver operating characteristic curves (AUC [95% CI]) for NOPP detection based on CpG methylation level was calculated for each locus. Further, a multivariable logistic regression model for NOPP prediction based on a combination of loci was generated. Gene functional enrichment and Ingenuity pathway analysis were performed to elucidate the molecular pathogenesis of NOPP. RESULTS: The was no difference between cases vs controls in: median (range) gestational age (weeks) at delivery, 39.5 (37.6-41.1) vs 39.6 (38.1-41.0), p¼0.54 or maternal age (years), 30.5 (23-42) vs 31.0 (19-37), p¼0.75. The NOPP group had higher parity compared to controls (2.0 [1-5] vs 1.5 [1-2], p¼0.02). The median number of days post-partum to readmission in NOPP was 7.5 (3-20). There were 538 (540 separate genes) significantly differentially methylated loci (FDR p 0.05) and with a !2.0-fold methylation difference and therefore likely to be biologically significant between the groups. A total of 143 individual CpG markers had excellent to outstanding predictive accuracy (AUC !0.80) for NOPP detection (subset shown in Table 1 ). A multivariate model based on 9 CpG markers yielded an AUC ¼1.0, (100% sensitivity and specificity). Ingenuity Pathway analysis revealed dysregulation of important pathways (e.g., angiogenesis and epithelial mesenchymal transition) known to be involved in classic preeclampsia, and also previously undescribed genes/ pathways (Figure 1) . CONCLUSION: In a novel study, NOPP shared both common and unique pathogenetic features with classic preeclampsia. Putative epigenomic biomarkers displayed high accuracy for NOPP prediction.
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